
|Articles|May 1, 2004
Integrated analysis underlines etanercept efficacy in psoriasis
Washington - Results of a multistudy analysis reinforce the efficacy of subcutaneous etanercept (Enbrel, Amgen) for inducing rapid and sustained improvement in patients with chronic plaque psoriasis, said Kenneth Gordon, M.D., at the annual meeting of the American Academy of Dermatology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
2
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
3
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
4
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
5











